BioSpace News Archive

Medimorphic, a global healthcare company that offers medicinal cannabis-based solutions with pharmaceutical industry precision, has appointed Blaine Warkentine, M.D. chief medical officer and Patrick Denton chief market officer. In their new roles, Dr. Warkentine and Mr. Denton will work together to develop innovative consumer and patient education programs.

HealthWarehouse.com, Inc. (OTC Pink:HEWA), a Verified Internet Pharmacy Practice Site (VIPPS) accredited online pharmacy licensed and/or authorized to sell in all 50 states serving consumers who pay out of pocket for their prescriptions, today announced that its shareholders have elected nominees to new one-year terms on its Board of Directors and ratified the appointment of its auditing firm for the 2019 fiscal year.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical Officer.

The National Association of Chronic Disease Directors CEO John W. Robitscher, MPH, and Board President Mónica Morales, MPA, welcome the FY20 Board of Directors, whose term begins Oct. 1 and will continue through Sept. 30, 2020.

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that Jennifer Buell, PhD, Chief Operating Officer of Agenus, present an update on Agenus’ progress and host one-on-one meetings with investors at the 2019 Cantor Global Healthcare Conference on October 4th, 2019

Since its September 2018 initial public offering (IPO), Elanco Animal Health Inc. (NYSE: ELAN) has continued to evaluate its capabilities, structure and staffing to meet its goal of being an agile, standalone company, focused exclusively on animal health and delivering on its Innovation, Portfolio and Productivity (IPP) strategy.

Centene Corporation (NYSE: CNC) announced today that David P. Thomas has been appointed Executive Vice President of Markets, for Centene, effective October 13, 2019

Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that it entered into an amended agreement related to its existing credit facility with SWK Funding LLC (“SWK”) and that it received a waiver letter from SWK related to certain financial covenants for Q3 2019.

Amoy Diagnostics Co., Ltd (AmoyDx, SZSE:300685), a leading company in companion diagnostics for precision oncology, today announced that the AmoyDx Lung Cancer PCR Panel has been accepted as first-line screening for patients who will potentially benefit from targeted therapy in the Lung Cancer Genomic Screening Project for Individualized Medicine (LC-SCRUM) in Japan.

Genomma Lab Internacional, S.A.B. de C.V. announced that it prepaid the total amortization for local bond “LAB 14", adding to the principal the accrued interest.